{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:22:53Z","timestamp":1792196573009,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mucosa melanoma is a rare condition with aggressive behavior and a less favorable prognosis compared to cutaneous melanoma. The objective of this study was to estimate the overall survival and clinical outcomes of patients diagnosed with mucosal melanoma in a Colombian hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study was conducted at Fundaci\u00f3n Valle del Lili, a single center located in Cali, Colombia. Patients aged\u2009\u2265\u200918\u00a0years, both sexes, diagnosed with mucosal melanoma by histopathology study were included between 2010\u20132019. Patients who received extra-institutional treatment or whose vital status was unknown during follow-up were excluded. Demographic, clinical and laboratory data were obtained from medical records and laboratory and pathology databases. A descriptive analysis was performed. Survival analysis was conducted using the Kaplan\u2013Meier method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 23 patients were included. Median age was 63\u00a0years old (IQR: 57\u201368) and 52.2% were woman. Clinical stage was 34.8% early, 26.1% locally advanced and 39.1% metastatic. The main primary locations were nasopharynx (30.4%), genitals (26.1%), rectum (21.7%), oral cavity (13%) and paranasal sinuses (8.7%). The majority received surgery (30.4%) and immunotherapy (26.1%) as first line treatment.<\/jats:p><jats:p>Overall survival at one year was 80.8%, at three years 44.3%, and at five years 36.9%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Mucosal melanoma is a rare, aggressive disease with adverse oncological outcomes due to late diagnosis and limited treatment options. This study provides real-world data in a single-center of Colombia.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-024-12371-x","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T07:02:01Z","timestamp":1721718121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival of patients with mucosal melanoma in Cali, Colombia: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ana M.","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Parra-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Mendoza-Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0846-8129","authenticated-orcid":false,"given":"\u00c1ngela","family":"Zambrano Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"12371_CR1","doi-asserted-by":"publisher","unstructured":"Yde SS, Sjoegren P, Heje M, Stolle LB. Mucosal Melanoma: a Literature Review. Curr Oncol Rep.\u00a02018;20(28):1\u20139. https:\/\/doi.org\/10.1007\/s11912-018-0675-0.","DOI":"10.1007\/s11912-018-0675-0"},{"key":"12371_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","volume":"112","author":"PA Ascierto","year":"2017","unstructured":"Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 2017;112:136\u201352.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"12371_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cps.2021.05.010","volume":"48","author":"D Olla","year":"2021","unstructured":"Olla D, Neumeister MW. Mucosal Melanoma. Clin Plast Surg. 2021;48(4):707\u201311.","journal-title":"Clin Plast Surg"},{"issue":"8","key":"12371_CR4","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma. Cancer. 1998;83(8):1664\u201378.","journal-title":"Cancer"},{"key":"12371_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-3-319-22539-5_13","volume":"167","author":"KR Spencer","year":"2016","unstructured":"Spencer KR, Mehnert JM. Mucosal melanoma: Epidemiology, biology and treatment. Cancer Treat Res. 2016;167:295\u2013320.","journal-title":"Cancer Treat Res"},{"key":"12371_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.humpath.2018.05.004","volume":"79","author":"M Ren","year":"2018","unstructured":"Ren M, Lu Y, Lv J, Shen X, Kong J, Dai B, et al. Prognostic factors in primary anorectal melanoma: a clinicopathological study of 60 cases in China. Hum Pathol. 2018;79:77\u201385.","journal-title":"Hum Pathol"},{"issue":"8","key":"12371_CR7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5858\/2003-127-997-CDIMMA","volume":"127","author":"ML Prasad","year":"2003","unstructured":"Prasad ML, Busam KJ, Patel SG, Hoshaw-Woodard S, Shah JP, Huvos AG. Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. Arch Pathol Lab Med. 2003;127(8):997\u20131002.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"12371_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182.","journal-title":"Histopathology"},{"key":"12371_CR9","doi-asserted-by":"crossref","unstructured":"Bravo L, Garcia L, Collazos P, Carrascal E, Grillo-Ardila E, Millan E, et al. Cancer epidemiology in Cali, 60 years of experience. Colombia M\u00e9dica. 2022;53(1 SE-Original Articles):1-28.","DOI":"10.25100\/cm.v53i1.5050"},{"key":"12371_CR10","doi-asserted-by":"crossref","unstructured":"Arias-Ortiz N, Rodr\u00edguez-Betancourt JD. Trends in cancer incidence and mortality in Manizales, Colombia, 2008\u20132017. Colombia M\u00e9dica. 2022;53(1 SE-Original Articles):1-14.","DOI":"10.25100\/cm.v53i1.4920"},{"key":"12371_CR11","doi-asserted-by":"crossref","unstructured":"Chamorro MY, Goyes LB, Fajardo DJ, Huertas SM, Cruz HC. Incidence and mortality by cancer in the Pasto municipality, Colombia. 2013\u20132017. Colombia M\u00e9dica. 2022;53(1 SE-Original Articles):1-16.","DOI":"10.25100\/cm.v53i1.4952"},{"key":"12371_CR12","first-page":"1","volume":"2020","author":"D Administrativo","year":"2020","unstructured":"Administrativo D, de Planeaci\u00f3n. Cali en cifras,. Departamen. Escobar Morales G, Perilla Galvis DM, editors. Cali. 2020;2020:1\u2013220.","journal-title":"Cali"},{"issue":"3","key":"12371_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10552-021-01532-z","volume":"33","author":"LG Parra-Lara","year":"2022","unstructured":"Parra-Lara LG, Mendoza-Urbano DM, Zambrano \u00c1R, Valencia-Orozco A, Bravo-Oca\u00f1a JC, Bravo-Oca\u00f1a LE, et al. Methods and implementation of a Hospital-Based Cancer Registry in a major city in a low-to middle-income country: the case of Cali. Colombia Cancer Causes & Control. 2022;33(3):381\u201392.","journal-title":"Colombia Cancer Causes & Control"},{"issue":"491","key":"12371_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.25100\/cm.v49i1.3853","volume":"49","author":"LS Garc\u00eda","year":"2018","unstructured":"Garc\u00eda LS, Bravo LE, Collazos P, Ram\u00edrez O, Carrascal E, Nu\u00f1ez M, et al. Colombia Cali Cancer Registry Methods. Colomb Med. 2018;49(491):109\u201320.","journal-title":"Colomb Med"},{"issue":"1","key":"12371_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.25100\/cm.v49i1.3689","volume":"49","author":"LE Bravo","year":"2018","unstructured":"Bravo LE, Garc\u00eda LS, Collazos P, Carrascal E, Ram\u00edrez O, Collazos T, et al. Reliable information for cancer control in Cali. Colombia Colombia Medica. 2018;49(1):23\u201334.","journal-title":"Colombia Colombia Medica"},{"key":"12371_CR16","unstructured":"American College of Surgeons. AJCC Cancer Staging Manual. 8th ed. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al., editors. Switzerland: Springer International Publishing; 2017. 1\u20131032 p."},{"issue":"6","key":"12371_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"12371_CR18","first-page":"1135","volume":"32A","author":"G Buccheri","year":"1996","unstructured":"Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer\u00a0 (Oxford, England\u202f: 1990). 1996;32A(7):1135\u201341.","journal-title":"Eur J Cancer\u00a0 (Oxford, England\u202f: 1990)"},{"issue":"2","key":"12371_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (Oxford, England\u202f: 1990). 2009;45(2):228\u201347.","journal-title":"Eur J Cancer (Oxford, England\u202f: 1990)"},{"issue":"12","key":"12371_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680407","volume":"4","author":"L Mao","year":"2021","unstructured":"Mao L, Qi Z, Zhang L, Guo J, Si L. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions. Front Immunol. 2021;4(12): 680407.","journal-title":"Front Immunol"},{"issue":"3","key":"12371_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.6004\/jnccn.2012.0034","volume":"10","author":"RD Carvajal","year":"2012","unstructured":"Carvajal RD, Spencer SA, Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. Journal of the National Comprehensive Cancer Network\u202f: JNCCN. 2012;10(3):345\u201356.","journal-title":"Journal of the National Comprehensive Cancer Network : JNCCN"},{"issue":"8","key":"12371_CR22","first-page":"739","volume":"5","author":"M Mihajlovic","year":"2012","unstructured":"Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5(8):739\u201353.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"12371_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/annonc\/mdw694","volume":"28","author":"B Lian","year":"2017","unstructured":"Lian B, Cui CL, Zhou L, Song X, Zhang XS, Wu D, et al. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients. Annals of oncology\u202f: official journal of the European Society for Medical Oncology. 2017Apr;28(4):868\u201373.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"21\u201322","key":"12371_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00508-021-01847-6","volume":"133","author":"A Andrianakis","year":"2021","unstructured":"Andrianakis A, Kiss P, Pomberger M, Wolf A, Thurnher D, Tomazic PV. Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity: A single center experience and review of literature. Wien Klin Wochenschr. 2021;133(21\u201322):1137\u201347.","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"12371_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-57253-6","volume":"10","author":"D Cohen Goldemberg","year":"2020","unstructured":"Cohen Goldemberg D, de Melo AC, de Melo Pino LC, Thuler LCS. Epidemiological profile of mucosal melanoma in Brazil. Sci Rep. 2020;10(1):1\u20137.","journal-title":"Sci Rep"},{"issue":"1","key":"12371_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaad.2018.09.054","volume":"81","author":"L Altieri","year":"2019","unstructured":"Altieri L, Eguchi M, Peng DH, Cockburn M. Predictors of mucosal melanoma survival in a population-based setting. J Am Acad Dermatol. 2019;81(1):136\u2013142.e2.","journal-title":"J Am Acad Dermatol"},{"issue":"34","key":"12371_CR27","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.2217\/fon-2019-0465","volume":"15","author":"A Al-Haseni","year":"2019","unstructured":"Al-Haseni A, Vrable A, Qureshi MM, Mathews S, Pollock S, Truong MT, et al. Survival outcomes of mucosal melanoma in the USA. Future oncology (London, England). 2019Dec;15(34):3977\u201386.","journal-title":"Future oncology (London, England)"},{"issue":"1","key":"12371_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1590\/S1808-86942011000100010","volume":"77","author":"B Khademi","year":"2011","unstructured":"Khademi B, Bahranifard H, Nasrollahi H, Mohammadianpanah M. Primary mucosal melanoma of the sinonasal tract: report of 18 patients and analysis of 1077 patients in the literature. Braz J Otorhinolaryngol. 2011;77(1):58\u201364.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"5","key":"12371_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11912-012-0244-x","volume":"14","author":"MA Postow","year":"2012","unstructured":"Postow MA, Hamid O, Carvajal RD. Mucosal melanoma: Pathogenesis, clinical behavior, and management. Curr Oncol Rep. 2012;14(5):441\u20138.","journal-title":"Curr Oncol Rep"},{"key":"12371_CR30","doi-asserted-by":"crossref","unstructured":"Carvajal RD, Spencer SA, Lydiatt W. Mucosal Melanoma: A Clinically and Biologically Unique Disease Entity. Journal of the National Comprehensive Cancer Network. 2012 [cited 2023 Oct 25];10(3):345\u201356. Available from: https:\/\/jnccn.org\/view\/journals\/jnccn\/10\/3\/article-p345.xml","DOI":"10.6004\/jnccn.2012.0034"},{"key":"12371_CR31","doi-asserted-by":"publisher","unstructured":"Jung S, Johnson DB, Management of Acral and Mucosal Melanoma: Medical Oncology Perspective. Oncologist. [cited 2023 Oct 25];27:703\u201310. Available from: 2022. https:\/\/doi.org\/10.1093\/oncolo\/oyac091.","DOI":"10.1093\/oncolo\/oyac091"},{"issue":"2","key":"12371_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","volume":"35","author":"SP D\u2019Angelo","year":"2017","unstructured":"D\u2019Angelo SP, Larkin J, Sosman JA, Lebb\u00e9 C, Brady B, Neyns B, et al. Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. J Clin Oncol. 2017;35(2):226 [cited 2023 Oct 25]. Available from:\/pmc\/articles\/PMC5559888\/.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12371-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T16:25:20Z","timestamp":1732465520000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12371-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12371"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12371-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the IRB \u2013 Comit\u00e9 de \u00c9tica en Investigaci\u00f3n Biom\u00e9dica (Protocol number 1642, Minutes 22\u20132020, of August 12, 2020), in accordance with the provisions of the Declaration of Helsinki and local regulations. Written informed consent was deemed unnecessary according to national legislation (Resolution 8430\/1993, Ministry of Health of Colombia).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"886"}}